Sign in
Back
Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease.
Journal article   Peer reviewed

Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease.

James A. Solomon, Michael Oswalt, Michael Nodzenski, Julie Glener, Matthew R. Schaeffer, Todd V. Cartee, Ian A. Maher, Joseph F. Sobanko, Abigail Waldman, Simon Yoo, …
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], Vol.45(5), pp.640-649
2019
DOI: https://doi.org/10.1097/dss.0000000000001865

Abstract

BACKGROUNDRecent increase in skin biopsies has been attributed to an epidemic of skin cancer. This may be avoidable, with potential savings.OBJECTIVETo determine whether the increase in skin biopsies is attributable to increasing frequency of biopsies associated with histology lacking pathological c
url
https://lens.org/050-829-424-139-187View
url
https://europepmc.org/article/MED/30829782View
url
https://pennstate.pure.elsevier.com/en/publications/assessing-skin-biopsy-rates-for-histologic-findings-indicative-ofView
url
https://scholarlycommons.baptisthealth.net/se-all-publications/3119/View
url
https://experts.umn.edu/en/publications/assessing-skin-biopsy-rates-for-histologic-findings-indicative-ofView

Metrics

13 Record Views

Details